Siegfried Barbera, SL recalls Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Va…
- Recall date
- November 20, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0149-2024
- FDA classification
- Class III
- Brand / firm
- Siegfried Barbera, SL
- Sold / distributed
- Nationwide
Why it was recalled
Failed Dissolution Specifications
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Valles, Spain, Distributed by: Novartis Pharmaceuticals Corp., East Hanover, N.J. 07936, NDC 0078-1077-66
Get recall alerts
Free email alert whenever Siegfried Barbera, SL has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Siegfried Barbera, SL